Skip to main content

Table 3 Clinical outcomes of TAE without hysteroscopic resection

From: Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding

Expectant management group (n = 15)
Follow-up period [months; mean (range)] 3.4 (1–17)
Clinical success* 15 (100%)
Vascularity of retained placenta on TVUS or CE-CT [n (%)]
Few days after TAE
Marked reduction 8 (53%)
 Disappearance 7 (47%)
More than 1 month after TAE
 Disappearance 15 (100%)
Vaginal bleeding after TAE [n (%)]
 No bleeding 14 (93%)
 Minimal bleeding** 1 (7%)
  1. *Clinical success was defined as the absence of re-bleeding requiring additional treatment in the conservative treatment group
  2. ** Minimal bleeding spontaneously disappeared within 1 month
  3. TVUS transvaginal ultrasound, CE-CT contrast-enhanced CT, TAE transarterial embolization